162 related articles for article (PubMed ID: 28820713)
1. Quality Testing of Artemisinin-Based Antimalarial Drugs in Myanmar.
Guo S; Kyaw MP; He L; Min M; Ning X; Zhang W; Wang B; Cui L
Am J Trop Med Hyg; 2017 Oct; 97(4):1198-1203. PubMed ID: 28820713
[TBL] [Abstract][Full Text] [Related]
2. Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.
Tivura M; Asante I; van Wyk A; Gyaase S; Malik N; Mahama E; Hostetler DM; Fernandez FM; Asante KP; Kaur H; Owusu-Agyei S
BMC Pharmacol Toxicol; 2016 Oct; 17(1):48. PubMed ID: 27788677
[TBL] [Abstract][Full Text] [Related]
3. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.
Dondorp AM; Newton PN; Mayxay M; Van Damme W; Smithuis FM; Yeung S; Petit A; Lynam AJ; Johnson A; Hien TT; McGready R; Farrar JJ; Looareesuwan S; Day NP; Green MD; White NJ
Trop Med Int Health; 2004 Dec; 9(12):1241-6. PubMed ID: 15598255
[TBL] [Abstract][Full Text] [Related]
4. Falsified antimalarials: a minireview.
Chaccour C; Kaur H; Del Pozo JL
Expert Rev Anti Infect Ther; 2015 Apr; 13(4):505-9. PubMed ID: 25683870
[TBL] [Abstract][Full Text] [Related]
5. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
6. Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana.
El-Duah M; Ofori-Kwakye K
J Vector Borne Dis; 2012 Sep; 49(3):131-9. PubMed ID: 23135006
[TBL] [Abstract][Full Text] [Related]
7. Development of a colloidal gold-based lateral flow dipstick immunoassay for rapid qualitative and semi-quantitative analysis of artesunate and dihydroartemisinin.
He L; Nan T; Cui Y; Guo S; Zhang W; Zhang R; Tan G; Wang B; Cui L
Malar J; 2014 Mar; 13():127. PubMed ID: 24678609
[TBL] [Abstract][Full Text] [Related]
8. Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria.
Kaur H; Allan EL; Mamadu I; Hall Z; Ibe O; El Sherbiny M; van Wyk A; Yeung S; Swamidoss I; Green MD; Dwivedi P; Culzoni MJ; Clarke S; Schellenberg D; Fernández FM; Onwujekwe O
PLoS One; 2015; 10(5):e0125577. PubMed ID: 26018221
[TBL] [Abstract][Full Text] [Related]
9. Detection of Poor Quality Artemisinin-based Combination Therapy (ACT) Medicines Marketed in Benin Using Simple and Advanced Analytical Techniques.
Yemoa A; Habyalimana V; Mbinze JK; Crickboom V; Muhigirwa B; Ngoya A; Sacre PY; Gbaguidi F; Quetin-Leclercq J; Hubert P; Marini RD
Curr Drug Saf; 2017; 12(3):178-186. PubMed ID: 28625144
[TBL] [Abstract][Full Text] [Related]
10. Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
Newton PN; Green MD; Mildenhall DC; Plançon A; Nettey H; Nyadong L; Hostetler DM; Swamidoss I; Harris GA; Powell K; Timmermans AE; Amin AA; Opuni SK; Barbereau S; Faurant C; Soong RC; Faure K; Thevanayagam J; Fernandes P; Kaur H; Angus B; Stepniewska K; Guerin PJ; Fernández FM
Malar J; 2011 Dec; 10():352. PubMed ID: 22152094
[TBL] [Abstract][Full Text] [Related]
11. Relationship between treatment-seeking behaviour and artemisinin drug quality in Ghana.
Klein EY; Lewis IA; Jung C; Llinás M; Levin SA
Malar J; 2012 Apr; 11():110. PubMed ID: 22482747
[TBL] [Abstract][Full Text] [Related]
12. Quality of Artemisinin-Containing Antimalarials in Tanzania's Private Sector--Results from a Nationally Representative Outlet Survey.
Act Consortium Drug Quality Project Team And The Impact Study Team
Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):75-86. PubMed ID: 25897065
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
14. Validation of ELISA for quantitation of artemisinin-based antimalarial drugs.
Wang M; Cui Y; Zhou G; Yan G; Cui L; Wang B
Am J Trop Med Hyg; 2013 Dec; 89(6):1122-8. PubMed ID: 24080636
[TBL] [Abstract][Full Text] [Related]
15. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
[TBL] [Abstract][Full Text] [Related]
16. Quality of artemisinin-based antimalarial drugs marketed in Nigeria.
Izevbekhai O; Adeagbo B; Olagunju A; Bolaji O
Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):90-96. PubMed ID: 28460126
[TBL] [Abstract][Full Text] [Related]
17. Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model.
Jackson KD; Higgins CR; Laing SK; Mwila C; Kobayashi T; Ippolito MM; Sylvia S; Ozawa S
BMC Public Health; 2020 Jul; 20(1):1083. PubMed ID: 32646393
[TBL] [Abstract][Full Text] [Related]
18. Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo.
Atemnkeng MA; De Cock K; Plaizier-Vercammen J
Trop Med Int Health; 2007 Jan; 12(1):68-74. PubMed ID: 17207150
[TBL] [Abstract][Full Text] [Related]
19. A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better.
Tabernero P; Mayxay M; Culzoni MJ; Dwivedi P; Swamidoss I; Allan EL; Khanthavong M; Phonlavong C; Vilayhong C; Yeuchaixiong S; Sichanh C; Sengaloundeth S; Kaur H; Fernández FM; Green MD; Newton PN
Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):95-104. PubMed ID: 25897062
[TBL] [Abstract][Full Text] [Related]
20. Rapid evaluation of artesunate quality with a specific monoclonal antibody-based lateral flow dipstick.
Guo S; Zhang W; He L; Tan G; Min M; Kyaw MP; Wang B; Cui L
Anal Bioanal Chem; 2016 Sep; 408(22):6003-8. PubMed ID: 26873200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
